STAGE IIA BREAST CANCER AJCC V6 AND V7
Clinical trials for STAGE IIA BREAST CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA BREAST CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE IIA BREAST CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise against tough breast cancer
Disease control CompletedThis phase 2 trial tested whether adding carboplatin and/or bevacizumab to standard chemotherapy before surgery helps shrink tumors in people with a hard-to-treat type of breast cancer (hormone receptor-poor, HER2-negative, including triple-negative). 454 participants received we…
Matched conditions: STAGE IIA BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New combo shows promise for aggressive breast cancer
Disease control CompletedThis study tested a combination of enzalutamide (a hormone blocker) and paclitaxel (chemotherapy) given before surgery to 24 people with a specific type of triple-negative breast cancer that has androgen receptors. The goal was to see if this treatment could shrink tumors and red…
Matched conditions: STAGE IIA BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New combo aims to stop breast cancer return after surgery
Disease control CompletedThis phase II study tested a combination of two chemotherapy drugs (cyclophosphamide and paclitaxel) plus the targeted drug trastuzumab given after surgery to 20 patients with early-stage HER2-positive breast cancer. The goal was to see if this regimen is safe and can help preven…
Matched conditions: STAGE IIA BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for tough breast cancer: drug cocktail targets resistant tumors
Disease control CompletedThis phase II trial tested a combination of panitumumab (a targeted therapy) plus two chemotherapy drugs (carboplatin and paclitaxel) given before surgery to women with triple-negative breast cancer that didn't respond to standard chemo. The goal was to shrink tumors and reduce t…
Matched conditions: STAGE IIA BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Smart pill bottles and video visits boost cancer drug adherence
Symptom relief CompletedThis study tested whether using telehealth visits and smart pill bottles can help breast cancer patients take their hormone therapy as prescribed. 305 women and men with early-stage hormone receptor-positive breast cancer participated. They either had regular in-person checkups o…
Matched conditions: STAGE IIA BREAST CANCER AJCC V6 AND V7
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC